CN111278846B - 抗微生物四肽 - Google Patents

抗微生物四肽 Download PDF

Info

Publication number
CN111278846B
CN111278846B CN201880070344.6A CN201880070344A CN111278846B CN 111278846 B CN111278846 B CN 111278846B CN 201880070344 A CN201880070344 A CN 201880070344A CN 111278846 B CN111278846 B CN 111278846B
Authority
CN
China
Prior art keywords
compound
cosmetic
formula
skin
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880070344.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN111278846A (zh
Inventor
马克·海德尔
艾琳·杰克逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of CN111278846A publication Critical patent/CN111278846A/zh
Application granted granted Critical
Publication of CN111278846B publication Critical patent/CN111278846B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN201880070344.6A 2017-10-30 2018-10-29 抗微生物四肽 Active CN111278846B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17199080.7 2017-10-30
EP17199080 2017-10-30
PCT/EP2018/079522 WO2019086361A1 (en) 2017-10-30 2018-10-29 Antimicrobial tetrapeptides

Publications (2)

Publication Number Publication Date
CN111278846A CN111278846A (zh) 2020-06-12
CN111278846B true CN111278846B (zh) 2023-10-27

Family

ID=60409114

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880070344.6A Active CN111278846B (zh) 2017-10-30 2018-10-29 抗微生物四肽

Country Status (7)

Country Link
US (1) US20200308222A1 (enExample)
EP (1) EP3704134B1 (enExample)
JP (1) JP7231307B2 (enExample)
KR (1) KR102694657B1 (enExample)
CN (1) CN111278846B (enExample)
BR (1) BR112020008175A2 (enExample)
WO (1) WO2019086361A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023242006A1 (en) * 2022-06-15 2023-12-21 Dsm Ip Assets B.V. Use of uv filters for the treatment of acne
WO2025174058A1 (ko) * 2024-02-15 2025-08-21 (주)뉴트리 탈모 유발 유해균에 대한 항균 효과를 갖는 두피 유래 펩타이드

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014081845A2 (en) * 2012-11-21 2014-05-30 University Of Cincinnati Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466492A1 (en) 1979-10-03 1981-04-10 Elf Aquitaine Dyeing keratin substances, e.g. skin, nails, hair, fur - with compsns. contg. ketone or aldehyde dye and sulphoxy-aminoacid
FR2651126B1 (fr) 1989-08-29 1991-12-06 Oreal Association de dihydroxyacetone et de derives indoliques pour conferer a la peau une coloration similaire au bronzage naturel et procede de mise en óoeuvre.
FR2661673B1 (fr) 1990-05-07 1992-08-21 Oreal Association de dihydroxyacetone et de monohydroxyindoles pour conferer a la peau une coloration similaire au bronzage naturel, dispositif a plusieurs compartiments et procede de mise en óoeuvre.
DE19603018C2 (de) 1996-01-17 1998-02-26 Lancaster Group Gmbh Kosmetisches Selbstbräunungsmittel mit Lichtschutzwirkung
FR2746391B1 (fr) 1996-03-22 1998-04-17 Oreal Compositions cosmetiques a base de pyrazolin-4,5-diones, nouvelles pyrazolin-4,5 diones, procedes de preparation et utilisations
FR2761595B1 (fr) 1997-04-04 1999-09-17 Oreal Compositions comprenant des santalines, santarubines pour la coloration artificielle de la peau et utilisations
FR2768733B1 (fr) 1997-09-19 1999-10-29 Oreal Nouveaux composes 4,4-dihydroxypyrazolin-5-ones ; leurs procedes de preparation et utilisations cosmetiques
FR2780281B1 (fr) 1998-06-26 2000-08-18 Oreal Compositions comprenant des nanopigments d'oxydes de fer pour la coloration artificielle de la peau et utilisations
WO2012158960A2 (en) * 2011-05-17 2012-11-22 H. Lee Moffitt Cancer Center & Research Institute, Inc. Melanocortin 1 receptor ligands and methods of use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014081845A2 (en) * 2012-11-21 2014-05-30 University Of Cincinnati Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Bioisosterism: A Rational Approach in Drug Design;George A. Patani 等;Chemical Reviews;第96卷(第8期);第3147页第1段-第3148页第2段 *
Characterization of aliphatic, cyclic, and aromatic N-terminally ‘‘capped’’ His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors;Jerry Ryan Holder 等;European Journal of Pharmacology;第462卷;摘要，图2的（13） *
Discovery of an ultra-short linear antibacterial tetrapeptide with anti-MRSA activity from a structure-activity relationship study;Qiu Ying Lau 等;European Journal of Medicinal Chemistry;第105卷;全文 *
L. N. Koikov 等.Sub-Nanomolar hMC1R Agonists by End-Capping of the Melanocortin Tetrapeptide His-D-Phe-Arg-Trp-NH2.Bioorganic and Medicinal Chemistry Letters.2003,第13卷化合物16-19. *
New Quinoxaline Derivatives as Potential MT1 and MT2 Receptor Ligands;Saioa Ancizu 等;Molecules;第17卷;摘要，第7739页第3段，第7744页第3段，图2 *
Sub-Nanomolar hMC1R Agonists by End-Capping of the Melanocortin Tetrapeptide His-D-Phe-Arg-Trp-NH2;L. N. Koikov 等;Bioorganic and Medicinal Chemistry Letters;第13卷;化合物16-19 *
Synthesis of the Naphthalenic Bioisostere of Indorenate;Said Yous 等;Arch. Pharm. (Weinheim);第326卷;Scheme1 *

Also Published As

Publication number Publication date
US20200308222A1 (en) 2020-10-01
BR112020008175A2 (pt) 2020-10-20
WO2019086361A1 (en) 2019-05-09
KR102694657B1 (ko) 2024-08-13
EP3704134A1 (en) 2020-09-09
EP3704134B1 (en) 2021-12-22
CN111278846A (zh) 2020-06-12
JP2021501133A (ja) 2021-01-14
KR20200073278A (ko) 2020-06-23
JP7231307B2 (ja) 2023-03-01

Similar Documents

Publication Publication Date Title
EP2928484B1 (en) Compounds useful in the treatment and/or care of the skin, hair and/or mucous membranes and their cosmetic or pharmaceutical compositions
US20100286056A1 (en) Compositions for reducing oxidative stress and uses thereof
CN111278846B (zh) 抗微生物四肽
EP3523316B1 (en) Melanocortin-1-receptor agonists
CN109689676B (zh) 新型化合物
WO2017093093A1 (en) Phosphinic peptide derivatives for use as mmp-12 inhibitors
EP3383881A1 (en) Phosphinic peptide derivatives for use as mmp-12 inhibitors

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant